ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) announced today that the Company will be participating in the Rodman & Renshaw 13th Annual Global Investment Conference being held at the Waldorf-Astoria Hotel in New York City from September 11th – 13th. J.J. Finkelstein, RegeneRx’s president and chief executive officer, will deliver the Company’s corporate presentation on Tuesday, September 13th, at 2:00 p.m. (Eastern Time).
